We can’t show the full text here under this license. Use the link below to read it at the source.
A prognosis model for predicting immunotherapy response of esophageal cancer based on oxidative stress-related signatures
Predicting esophageal cancer response to immunotherapy using oxidative stress markers
AI simplified
Abstract
A risk score (RS) model was developed to predict the prognosis of esophageal squamous cell carcinoma (ESCC) based on oxidative stress-related genes.
- Survival rates were lower in high-risk groups compared to low-risk groups as determined by the RS model.
- The model demonstrated strong predictive performance, with an area under the curve (AUC) verified in two cohorts.
- Independent prognostic analysis identified the RS as an independent risk factor for ESCC.
- Increased expression of five specific genes (MPC1, COX6C, CYB5R3, CASP7, and CYCS) was detected in esophageal cancer patients.
- The nomogram developed from the RS provides favorable predictive value for the prognosis of ESCC patients.
AI simplified